Immutep (ASX:IMM) - Webinar Presentation Company Presentations by Finance News Network June 23, 2023 05:09 PM Marc Voigt - Executive Director & CEO - Immutep (ASX:IMM) is a clinical-stage biotechnology company at the forefront of developing novel LAG-3 immunotherapy for cancer and autoimmune diseases.
